Sentinel node biopsy in vulvar cancer: Implications for staging.

Area of Science:

• Gynecologic Oncology
• Surgical Pathology
• Cancer Staging

Background:

• The Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V) established the safety of omitting inguinofemoral lymphadenectomy in early-stage vulvar cancer with negative sentinel nodes.
• Pathologic ultrastaging of sentinel nodes has led to increased detection of smaller lymph node metastases.
• The clinical significance of these micrometastases and their impact on patient outcomes remains unclear.

Purpose of the Study:

• To investigate the clinical consequences of detected micrometastases in sentinel lymph nodes for early-stage vulvar cancer.
• To evaluate the relationship between the size of lymph node metastases and the risk of non-sentinel node involvement and survival.
• To inform potential revisions to the vulvar cancer staging system regarding micrometastases.

Main Methods:

• Review of data from patients undergoing sentinel lymph node procedures for early-stage vulvar cancer.
• Analysis of sentinel lymph node pathology, focusing on metastasis size and detection through ultrastaging.
• Correlation of metastasis size with clinical outcomes, including non-sentinel node metastasis and survival rates.

Main Results:

• Increased detection of smaller lymph node metastases due to enhanced pathologic examination.
• Emerging evidence suggests a correlation between increasing metastasis size and higher risks of non-sentinel node metastases and decreased survival.
• Current staging systems do not fully incorporate the clinical implications of micrometastases.

Conclusions:

• While sentinel node biopsy with ultrastaging is safe and reduces morbidity, the clinical impact of micrometastases requires further investigation.
• The size of sentinel lymph node metastases may have prognostic value that needs to be integrated into clinical practice and staging.
• Further research is essential to determine the precise clinical consequences of varying sizes of lymph node metastases in vulvar cancer.